Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

Concord Hospital, Sydney

Peter MacCallum Cancer Centre, Melbourne

Monash Hospital, Clayton

Sir Charles Gairdner Hospital, Nedlands

Harbin Medical University Cancer Hospital, Harbin

Shanghai jiaotong university school of medicine Ruijin Hospital, Shanghai

St Vincent's Hospital, Darlinghurst

Royal Hobart Hospital, Hobart

Epworth Healthcare, Richmond

Guangdong General Hospital, Guangzhou